Correlating QLV Interval to Left Ventricular (LV) Lead Position in Patients Receiving Cardiac Resynchronization Therapy.

Completed · Not applicable

Conditions studied: Heart Failure, Cardiomyopathy, Cardiac Arrhythmia

In brief

This is a prospective clinical trial to determine the optimal QLV interval during implantation to achieve the best possible response from cardiac resynchronization therapy for heart failure patients.

Key facts

Study ID

NCT02166762

Run by

University of California, San Diego

People needed

20

Starts

2013-05-01

Expected to finish

2015-09-01

Last updated by the study team

2019-06-07

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Patients who are indicated for CRT-D devices according to the current guidelines for implantation of cardiac pacemakers and antiarrhythmia devices

You may not qualify if…

• Patients who are under the age of 18
• Patients who are pregnant
• Patients who cannot have intravenous contrast due to allergic reactions or chronic renal insufficiency
• Patients who are unable or unwilling for any reason to consent for this study

Where it is running

• UCSD Sulpizio Cardiovascular Center — La Jolla, California, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.